COVID-19 information, guidance, and resources. Information about returning to campus.
Biomedical scientist explains how Covid-19 vaccines work
California residents 65 and older now qualify for COVID-19 vaccinations. Questions about the mRNA Covid-19 vaccines still remain. Vaccine expert Dr. David Lo, a distinguished professor of biomedical sciences and senior associate dean for research in the School of Medicine at the University of California, Riverside, answers several questions in...
New multicampus consortium to study assembly of coronaviruses
Host campus UC Riverside will be joined by UC Davis and UC Merced
Unraveling a mystery surrounding embryonic cells
Neural crest study results could boost stem cell therapies
Observed COVID-19 variability may have underlying molecular sources
UC Riverside-led study shows how variations in SARS-CoV-2 host gene expression can be linked to variations in COVID-19 susceptibility and symptom severity
Drug found to correct gene defect that causes immune-driven gut leakiness
UC Riverside-led study is the first to show how tofacitinib rescues gut barrier function from overactive immune cells
Developing a COVID-19 vaccine at warp speed
Dr. Paul Offit, an international expert on vaccines, will give the 2020 Thomas and Salma Haider Biomedical Breakthrough Lecture at UC Riverside
Brain protein linked to seizures, abnormal social behaviors
UC Riverside mouse study focused on neurons in the hippocampus
Improving treatment of spinal cord injuries
Osmotic therapy device reduces swelling to prevent secondary injuries in rats
Neurons are genetically programmed to have long lives
UC Riverside-led study identifies mechanism that prevents death of neurons
Cancer researcher named UCR medical school’s newest endowed chair
Adam Godzik has been named the Bruce D. and Nancy B. Varner Presidential Endowed Chair in Cancer Research
School of Medicine faculty receive grants to increase diversity in biomedical sciences, study incentives in research, boost mental health treatment
Total funding of three grants exceeds $1.2 million
Understanding a gene’s role in inflammatory bowel disease
UC Riverside mouse study will identify mechanisms the gene PTPN2 uses to affect gut cells
How the coronavirus could be prevented from invading a host cell
UC Riverside-led study shows inhibiting two host cell proteases can accomplish the task
Scientists to study how lungs respond to worm infections
Research supported by five-year NIH grant may have relevance for COVID-19 patients
How does soap kill the coronavirus?
UC Riverside biomedical scientist Marcus Kaul explains
New drug target found for COVID-19
Scientists discover critical protein complex that lets virus hide from immune system
New coronavirus protein reveals drug target
Drugs previously in development for SARS could be effective for COVID-19
Doubling down on cancer-causing genes
NIH grant of $2.2 million could help researchers target two oncogenes, potentially leading to therapies for melanoma, lung cancer, and other tumors
Drug decreases gut leakiness associated with ulcerative colitis
UC Riverside-led study is the first to show how tofacitinib affects epithelial cells lining the gut
Space travel can make the gut leaky
UC Riverside-led study tested the effects of microgravity on intestinal epithelial cells